At present, there is no distinctly effective treatment for hormone refractory prostate cancer. We describe a hormone refractory prostate cancer patient with rapidly progressive bone metastasis who showed dramatic response to intake of an extract from the mushroom, Phellinus linteus.
Department of Urology, Gunma University School of Medicine
3-39 Showa-machi, Maebashi, Gunma 371-8511 (Japan)
Tel. +81 27 220 8306, Fax +81 27 220 8318
Received: January 28, 2003
Revised and accepted: August 27, 2003
Number of Print Pages : 3
Number of Figures : 3, Number of Tables : 0, Number of References : 3
Founded 1955 by G. Peter A. Narath and Heinrich Heusser; Continued 1968–1987 by G. Mayor
Vol. 73, No. 2, Year 2004 (Cover Date: Released August 2004)
Journal Editor: D. Hauri, Zürich; M. Porena, Perugia; M.P. Wirth, Dresden
ISSN: 0042–1138 (print), 1423–0399 (Online)
For additional information: http://www.karger.com/uin
Article / Publication Details
Published online: 8/27/2004
Issue release date: August 2004
Number of Print Pages: 3
Number of Figures: 3
Number of Tables: 0
ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)
For additional information: http://www.karger.com/UIN
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.